Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

No association of breast cancer risk with integrin beta3 (ITGB3) Leu33Pro genotype.

British journal of cancer - 11 Jul 2005

Bojesen S E, Tybjaerg-Hansen A, Axelsson C K, Nordestgaard B G

Abstract excerpt

To pursue a borderline increased risk of breast cancer for carriers of two integrin beta(3) (ITGB3) 33Pro alleles found in a recent prospective study, we conducted a case-control study of 1088 women with breast cancer and 4815 female controls. Leu33Pro heterozygotes, homozygotes and heterozygotes+homozygotes vs noncarriers had odds ratios for breast cancer of 1.0 (95% confidence interval: 0.8-1.1), 0.8 (0.5-1.2)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over
Share to Breast Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Case-Control Studies

Share to Genetic Predisposition to Disease

Share to Integrin beta3

Share to Leucine

Share to Proline

Source

Open in PubMed Open full text

Identifiers

PMID: 15970922
DOI: 10.1038/sj.bjc.6602674
PMCID: PMC2361476

Genes

ITGB3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

No association of breast cancer risk with integrin beta3 (ITGB3) Leu33Pro genotype.PMID 15970922Read ↗

The Leu33Pro polymorphism in the ITGB3 gene does not modify BRCA1/2-associated breast or ovarian cancer risks: results from a multicenter study among 15,542 BRCA1 and BRCA2 mutation carriers.Semantic proximity Read ↗

Integrin beta3 Leu33Pro homozygosity and risk of cancer.Semantic proximity Read ↗

Increased risk of ovarian cancer in integrin beta3 Leu33Pro homozygotes.Semantic proximity Read ↗

Integrin alpha-2 and beta-3 gene polymorphisms and breast cancer risk.Semantic proximity Read ↗

The 825C>T polymorphism of the G-protein beta-3 subunit gene (GNB3) and breast cancer.Semantic proximity Read ↗

Integrin alpha-2 and beta-3 gene polymorphisms and colorectal cancer risk.Semantic proximity Read ↗

No association between OGG1 Ser326Cys polymorphism and breast cancer risk.Semantic proximity Read ↗

Integrin beta3 Leu33Pro polymorphism and risk of hip fracture: 25 years follow-up of 9233 adults from the general population.Semantic proximity Read ↗

No association of TGFB1 L10P genotypes and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a multi-center cohort study.Semantic proximity Read ↗

No association between the progesterone receptor gene +331G/A polymorphism and breast cancer.Semantic proximity Read ↗

No association between glutathione peroxidase Pro198Leu polymorphism and breast cancer risk.Semantic proximity Read ↗

The A(-336C) insulin-like growth factor binding protein-3 promoter polymorphism is not a modulator of breast cancer risk in Caucasian women.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.